Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 11, 2023

SELL
$223.05 - $302.68 $644,614 - $874,745
-2,890 Reduced 99.66%
10 $2,000
Q4 2022

Feb 13, 2023

SELL
$204.38 - $296.82 $61,314 - $89,046
-300 Reduced 9.38%
2,900 $596,000
Q3 2022

Nov 10, 2022

SELL
$195.21 - $310.53 $292,815 - $465,794
-1,500 Reduced 31.91%
3,200 $890,000
Q2 2022

Aug 12, 2022

SELL
$115.91 - $214.48 $115,910 - $214,480
-1,000 Reduced 17.54%
4,700 $898,000
Q3 2021

Oct 21, 2021

SELL
$163.99 - $235.57 $163,990 - $235,570
-1,000 Reduced 14.93%
5,700 $1.17 Million
Q2 2021

Jul 29, 2021

BUY
$131.45 - $201.49 $880,714 - $1.35 Million
6,700 New
6,700 $1.27 Million

Others Institutions Holding SWAV

About Shockwave Medical, Inc.


  • Ticker SWAV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,927,100
  • Description
  • ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease ...
More about SWAV
Track This Portfolio

Track Hillsdale Investment Management Inc. Portfolio

Follow Hillsdale Investment Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hillsdale Investment Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Hillsdale Investment Management Inc. with notifications on news.